Newsletter | February 24, 2025

02.24.25 -- Integrating Development Processes For Combination Products

SPONSOR

Take a tour of Nanoform's best-in-class nanodevelopment capabilities, setting new standards in innovation. Their highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. With 14 development lines for small molecules and 5 for large molecules, Nanoform offers unmatched scalability and precision. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers. Learn more.

FEATURED EDITORIAL

Integrating Development Processes For Combination Products

This discussion highlights key aspects of a biopharma organization’s business and operations that must be effectively integrated when developing drugs and devices in tandem. These include imperatives such as establishing common terminology, applying Quality by Design (QbD) principles, and managing supplier controls.

INDUSTRY INSIGHTS

Strategies For Lipid-Based Drug Delivery Systems And Oral Dosage Forms

Experts share principles, advantages and disadvantages of different dose forms, and considerations for selecting a suitable dosage form for early phase development programs to commercialization.

Producing OSD For Pediatrics And Other Special Population Delivery

Watch to hear Steven Facer, Adare's Vice President of Business Development EU/ROW, discuss the challenges of pediatric oral solid dose manufacturing and how to overcome them.

'Smart Devices' vs. 'Smart Design' In User-Centric Autoinjector Design

Experience the next generation of drug delivery with Oval Medical’s innovative Prefilled Primary Drug Container — designed to enhance compatibility, reliability, and user compliance.

Maintaining Superior Viral Vector Recovery In C&G Therapy Applications

Here, we review a study assessing the stability of vials aimed to determine if the vial material had any influence on the viral titer and particle counts of the AAV serotypes.

Evaluating The Impact Of Sterilization Methods On Stopper Performances

Three studies focus on a product designed to address unmet needs in subcutaneous drug therapies for chronic diseases, including sterilization methods and a Human Factors evaluation.

Autoinjectors: A Revolutionary Leap In Drug Delivery

Explore how the widespread adoption of autoinjectors is transforming the biopharmaceutical industry's approach to drug delivery, offering precise dosing, patient adherence, and safety.

PBPK Modeling To Mitigate Absorption Risks, Enhance Delivery

Discover how PBPK models combined with in vitro tools and solubility enhancement expertise can be used to identify and mitigate absorption risks in early drug development.

SOLUTIONS

Supporting A Range Of Combination Product Development

Highly Flexible And Customizable On-Body Delivery System Platform

Designed For Inhalation: Pulmonary And Nasal Delivery